Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$0.67 - $1.4 $13,400 - $28,000
20,000 Added 200.0%
30,000 $39,000
Q1 2021

May 13, 2021

BUY
$2.92 - $5.07 $29,200 - $50,700
10,000 New
10,000 $45,000

Others Institutions Holding SELB

About SELECTA BIOSCIENCES INC


  • Ticker SELB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 152,712,992
  • Market Cap $128M
  • Description
  • Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...
More about SELB
Track This Portfolio

Track Alerus Financial Na Portfolio

Follow Alerus Financial Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alerus Financial Na, based on Form 13F filings with the SEC.

News

Stay updated on Alerus Financial Na with notifications on news.